Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Akebia Therapeutics, Inc. (AKBA) had Return on Equity of -37.55% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$57.62M |
|
$-12.24M |
|
$12.54M |
|
$45.09M |
|
$66.17M |
|
$-8.55M |
|
$-2.68M |
|
$-11.23M |
|
$-11.23M |
|
$-12.24M |
|
$-12.24M |
|
$-12.24M |
|
$-12.24M |
|
$-8.55M |
|
$-8.23M |
|
257.16M |
|
257.16M |
|
$-0.05 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$252.96M |
|
$1.22M |
|
$123.61M |
|
$376.56M |
|
$162.94M |
|
$48.25M |
|
$181.02M |
|
$343.95M |
|
$32.61M |
|
$-26.43M |
|
$32.61M |
|
265.43M |
|
| Cash Flow Statement Financials | |
$67.99M |
|
$-7.93M |
|
$72.93M |
|
$53.55M |
|
$186.54M |
|
$132.99M |
|
$11.28M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.55 |
|
-- |
|
-- |
|
0.60 |
|
1.48 |
|
78.25% |
|
-14.84% |
|
-14.84% |
|
-- |
|
-19.50% |
|
-21.25% |
|
$67.87M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
0.80 |
|
1.23 |
|
73.46 |
|
|
Return on Equity |
-37.55% |
46.32% |
|
-3.25% |
|
-15.14% |
|
$0.12 |
|
$0.26 |
|
$0.26 |
|